The results showed that patterns of liver damage, PLT, ALT, AST, TBIL, and autoimmunity were significantly different in groups with increasing grades of hepatic inflammation (p < 0.05, Table 1) or in groups with increasing stages of hepatic fibrosis (p < 0.05, Table 2). This evidence concerns the gene GPT and Hepatic fibrosis.